American Gastroenterological Association Freston Single Topic Conference 2021

Description

+ Include: 16 videos, size: 7.59 GB

+ Target Audience: gastroenterologist

+ Sample video: contact me for sample video

+ Topics:

ACHALASIA.mp4
Breakout Emerging Therapeutics for Children. Pediatric Considerations, Personalized Approaches and Special Situations.mp4
Breakout Epidemiologic Trends – Why the Increase in Incidence Demographic Differences, Atopic Predisposition and Disease Associations.mp4
Breakout Natural History of EoE Does Every Patient Need Treatment.mp4
Breakout Remodeling & Fibrosis. How to Measure, Reversibility and Novel Therapeutics.mp4
BUILDING A BETTER PATH EOSINOPHILS IN EOE.mp4
CLOSING STATEMENTS.mp4
CROSSROADS EOSINOPHILS IN NON EGID GI DISORDERS.mp4
EOE – PATHOGENESIS.mp4
EOE – THERAPEUTIC ADVANCES.mp4
FUNCTIONAL GASTROINTESTINAL DISORDERS.mp4
INFLAMMATORY BOWEL DISEASE.mp4
INTRODUCTION AND PROGRAM OVERVIEW.mp4
NEW PATHS EOSINOPHILS IN EGIDS.mp4
SUMMARY OF BREAKOUT GROUPS.mp4
SUMMARY OF BREAKOUT GROUPS[2].mp4

 

 

* Detail:

EoE BUILDING A BETTER PATH: EOSINOPHILS IN EOE
Introduction Alex Straumann, MD – University of Zurich
Historical Perspective on EoE: Charting an Undiscovered Disease Stephen Attwood, MD – Durham University, United Kingdom
Global impact and Historical Perspective Alex Straumann, MD – University of Zurich
Patient Presentations – Consider Patient 0 Patient Jeffery O. and Mary M.

EoE – Pathogenesis Moderator Introduction  Sandeep Gupta, MD – Indiana University
Epidemiology: When and Where Did the Path Begin? Evan Dellon, MPH, MD – University of North Carolina School of Medicine
Genetics and Epigenetics: Genetic Determinants of the Path Marc Rothenberg, MD, PhD – Children’s Hospital Medical Center
Fibrosis: Influence of Subepithelial Activity on the Path Seema Aceves, PhD, MD – University of California, San Diego School of Medicine
Allergic Mechanisms: Crossroads with Food, Environmental and Extraesophageal Atopy (OIT, Food, Environmental) Jonathan Spergel, MD, PhD – Children’s Hospital of Philadelphia
Mast Cells and Epithelial Barrier Dysfunction: Inroads and Crossroads Joshua Wechsler, MD – Ann & Robert H. Lurie Children’s Hospital of Chicago
Summary and Discussion Quan Nhu, MD, Dominique Bailey, MD and Joy Chang, MD

EoE – Therapeutic Advances Moderator Introduction David Katzka, MD – Mayo Clinic
Diet Therapy Alfredo Lucendo, MD, PhD – Hospital General de Tomelloso
PPIs: Mechanism and Pathways in the Post AGREE Era Javier Molina-Infante, MD, PhD – Universitario San Pedro de Alcantara
Swallowed Topical Steroids: Repaving a Well-Trodden Path (Efficacy of Newest Agents, Maintenance, Safety) Gary Falk, MD – University of Pennsylvania Perelman School of Medicine
Biologics and Immune Modulators: Charting a New Course Ikuo Hirano, MD – Northwestern University School of Medicine
Therapeutics: Discussion Speaker Panel

BREAKOUTS
Diet Therapy. SOFEED, Novel Monitoring Ready for Prime TimeJohn Leung MD, Nirmala Gonsalves, MD, Kara Kliewer, RD and Bethany Doerfler, RD
Endpoints of Medical Therapy in Adults: Resolution of Inflammation David Katzka, MD, Margaret Collins, MD, Ikuo Hirano, MD, Jonathan Spergel, MD, PhD and Thomas Greuter, MD

SUMMARY OF BREAKOUT GROUPS
Case Presentation-EGE: Adult Gary Falk, MD – University of Pennsylvania Perelman School of Medicine Patient Lisa L.
Epidemiology: When and Where Did This Path Begin Elizabeth Jensen, PhD – Wake Forest School of Medicine
Clinical Features and Natural History: A Long and Winding Road Chris Liacouras, MD – Children’s Hospital of Philadelphia
Pathology: Diagnostic Thresholds for Eosinophil Density: New Roadmaps for an Old Disease Robert Genta, MD – Baylor College of Medicine
Pathology: Histologic Features Beyond Eosinophils: Off the Beaten Path Margaret Collins, MD – Cincinnati Children’s Hospital Medical Center
Pathogenesis: Building Bridges to Better Understanding Glenn Furuta, MD – Children’s Hospital Colorado
Outcomes and Biomarkers: Inroads into Uncharted Territory? Paneez Khoury, MD, MHSc – National Institute of Health
Therapeutics: Diet Therapies Nirmala Gonsalves, MD – Northwestern Memorial Hospital
Therapeutics: Novel Directions Kathryn Peterson, MD – University of Utah
Discussion Speaker Panel

Non-EGID Disorders: CROSSROADS: EOSINOPHILS IN NON EGID GI DISORDERS
CON: Achalasia in Not an EGID John Pandolfino, MD – Northwestern University
Consensus and Discussion Panel

INFLAMMATORY BOWEL DISEASE
Introduction Glenn Furuta, MD – Children’s Hospital Colorado Role of Eosinophils in IBD
Theresa Pizarro, PhD – Case Western Reserve University School of Medicine
Remodeling in IBD. Lessons for EGIDs Florian Rieder, MD – Cleveland Clinic Foundation
Management of IBD: Lessons for EGIDS Steven Hanauer, MD – Northwestern University Feinberg School of Medicine
Summary, Discussion and Q&A Panel

FUNCTIONAL GASTROINTESTINAL DISORDERS
Moderator Introduction John Pandolfino, MD – Northwestern University
PRO: Functional GI disorders are EGIDs Nicholas Talley, MD, PhD – University of Sydney, Australia
CON: Functional GI Disorders are Not EGIDs Brian Lacy, MD, PhD – Mayo Clinic